chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 24.0
Sex: F
Vaccine: MMR
Symptoms: Expired product administered, Injection site erythema
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 24 year old non-pregnant female patient. The patient had no pertinent medical history, no drug allergies/reactions and no concomitant therapy. On 22-FEB-2015 the patient was vaccinated with expired MMR II lot # H017027, expiry date 14-SEP-2014, 0.5 ml, subcutaneously, reason for vaccination: "needed for school". The patient developed "pinkish" color at the injection site after the vaccination. The outcome of the event was unknown. The relationship between the event and MMR II was not reported. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Exposure to vaccinated person, Herpes zoster, Secondary transmission
Clinical narrative: This spontaneous report as received from a nurse practitioner student, refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date in 2015, the patient experienced a Secondary Transmission, as he/she touched the injection site reaction on a classmate arm was vaccinated with ZOSTAVAX. Subsequently the patient was diagnosed with shingles. The outcome of shingles was unknown at the time of the report. This is one of two reports from the same reporter. Additional information has been requested.
Age: 80.0
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: This spontaneous report as received from a nurse, refers to a 80 year old male with no drug reactions/allergies. Patient's concurrent conditions and medical history were not reported. On 04-FEB-2015 the patient was vaccinated with a dose of M-M-R II, 0.5 ml, subcutaneously (lot # K005109,expiration date: 04-APR-2016), because titer for rubella showed no immunity. Concomitant therapies included FLOMAX, verapamil, hydrochlorothiazide, MAXIDE and dutasteride, JALYN. On 17-FEB-215, the patient experienced fever, that was as high as 104 F. On 18-FEB-2015 the patient experienced rash on the trunk of his body. The patient sought medical attention by calling physician's office. Fever was reduced after receiving ibuprofen. The outcome of the events was reported as recovering/resolving. Relatedness between the events and M-M-R II was not provided. Additional information has been requested.
Sex: U
Vaccine: DTAPIPV
Symptoms: Incorrect product storage
Clinical narrative: This case was reported by a other health professional and described the occurrence of incorrect storage of drug in a patient who received KINRIX (batch number 9947M, expiry date 3rd September 2016). On an unknown date, the patient received KINRIX. On an unknown date, an unknown time after receiving KINRIX, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional information received: This product has been exposed to temperature outside of the required temperature range and the efficacy of this product outside the temperature range has not been established. This customer purchased one 10 pack of this product therefore it was administered to 10 patients. the ages and genders of the patients are unknown at this time. This case is one of the 9 cases reported by the same reporter for the same vaccine.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Headache
Clinical narrative: Pt received injection #2 on 2/17/2015 and developed headache on 2/21/2015 not resolved with MOTRIN, pt's mother contacted office on 2/24/2015 to report headache.
Sex: F
Vaccine: HEP, HEPAB
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: This case was reported by a consumer and described the occurrence of inappropriate schedule of vaccination administered in a female patient who received TWINRIX. Co-suspect products included ENGERIX B. On an unknown date, the patient received TWINRIX at an unknown dose and ENGERIX B at an unknown dose. On an unknown date, an unknown time after receiving TWINRIX and ENGERIX B, the patient experienced inappropriate schedule of vaccine administered. On an unknown date, the outcome of the inappropriate schedule of vaccine administered was unknown. Additional information: Caller reports that she received a TWINRIX vaccine from her provider. One month later she received only a hepatitis B vaccine, not TWINRIX. This does not follow the dosing schedule for TWINRIX or ENGERIX-B.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report as received from a physician, as part of a marketing research program conducted by agency, refers to a patient of unknown age (reported as "65? (unsure)") and gender (reported as "male?"). The physician did not remember the patient's race. "4 or so years ago", in approximately 2011, the patient got shingles 7-10 days after receiving a single dose of ZOSTAVAX (lot#, dose and route were not provided). The outcome of the event was not provided. The reporter considered the event to be a co-incidence and he did not believe the shot caused the shingles because "with one million cases of shingles a year someone is bound to get them right after being vaccinated". Additional information has been requested.
Age: 52.0
Sex: F
Vaccine: HEP
Symptoms: Nausea, Rash, Rash erythematous
Clinical narrative: This case was reported by a other health professional via call center representative and described the occurrence of nausea in a 52-year-old female patient who received ENGERIX B adult (batch number 3FZ74, expiry date 29th August 2014). Previously experienced adverse reactions included drug allergy. On 5th January 2015 09:00, the patient received the 1st dose of ENGERIX B adult (intramuscular) 1 ml. On 5th January 2015 09:00, the dose was 1 ml. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On 6th January 2015, 1 days after receiving ENGERIX B adult, the patient experienced nausea. On 8th January 2015, the patient experienced rash. On 6th January 2015, the outcome of the nausea was recovered/resolved. On 12th January 2015, the outcome of the rash was recovering/resolving. The reporter considered the nausea to be probably related to ENGERIX B adult. The reporter considered the rash to be possibly related to ENGERIX adult. Additional information: Patient received first dose of ENGERIX-B and developed nausea one day afterwards and then a rash on both sides of the neck 3 days after the vaccination. The rash was raised and pink and was not itchy. No pustules or scabing. The nausea only lasted on day. The nausea is resolved and the rash is resolving.
Age: 0.98
Sex: U
Vaccine: MMR
Symptoms: Erythema, Pruritus, Pyrexia, Rash, Urticaria
Clinical narrative: Rash-trunk, itchy, erythematous, some urticaria. Fever-100-102 x 2 days.
Age: 1.0
Sex: M
Vaccine: HEPA, HIBV, MMRV, PNC13
Symptoms: Measles
Clinical narrative: Measle like reaction. Tx - none.
Age: 25.0
Sex: F
Vaccine: RAB
Symptoms: Gastrointestinal disorder, Headache, Lymph node pain, Lymphadenopathy, Middle insomnia
Clinical narrative: 102 degree fever. Headache. Right lymph node swelling, tenderness, arm tingling. Nausea. Intestinal "issues" was awakened during the night with these symptoms 2-2-15 Pt. had received RABAVERT.
Age: 25.0
Sex: F
Vaccine: RAB
Symptoms: Nausea, Paraesthesia, Pyrexia
Clinical narrative: 102 degree fever. Headache. Right lymph node swelling, tenderness, arm tingling. Nausea. Intestinal "issues" was awakened during the night with these symptoms 2-2-15 Pt. had received RABAVERT.
Age: 20.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Pt states she noticed the site of Varicella #2 itchy with redness and warm to the touch the day after injection. Pt states she has not scratched the site and now it is painful and she avoids touching the site.
Age: 17.0
Sex: M
Vaccine: HEPA
Symptoms: Pallor, Syncope
Clinical narrative: None stated.
Age: 0.17
Sex: M
Vaccine: DTAPIPV
Symptoms: Crying, Irritability
Clinical narrative: Crying/fussy
Sex: U
Vaccine: HEP
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report was received from a nurse refers to a patient of unknown age and gender. No pertinent medical history was reported. On 12-FEB-2015, the patient was vaccinated with expired dose of RECOMBIVAX HB INJ (lot # J001836 and expiration date 01-FEB-2015) (strength, dose and route were not reported). No adverse events reported. No product Quality Complaint (PQC) was involved. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: This spontaneous report as received from a nurse practitioner refers to a female patient of unknown age with warts on her hands. On an unknown date, approximately in 2009 (also reported as 5-6 years ago) the nurse practitioner administered the full series of GARDASIL (intramuscularly, dose, frequency and lot # not reported) to a female patient who was older than recommended age but who had warts on her hands. The nurse practitioner noted that the patient's warts resolved after the second dose of GARDASIL. The outcome of the event and relatedness between the event and GARDASIK were not reported. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Drug administered at inappropriate site, No adverse event
Clinical narrative: This spontaneous report was received from a consumer who was patient's friend refers to the female patient of unknown age. On an unknown date the patient was administered with ZOSTAVAX by an injection in her hip, which was other than indicated for injection of the vaccine. Outcome of the event was unknown. No side effects were mentioned. No product quality complaint (PQC) was involved. The reporter considered the event to be not related to ZOSTAVAX. Additional information has been requested.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Back pain, Herpes zoster, Rash
Clinical narrative: This spontaneous report as received from physician assistant refers to a female patient of unknown age. No medical history and concurrent conditions reported. On an unknown date of April-2011 the patient was vaccinated with ZOSTAVAX (dose, route, lot#, frequency not reported). There was no concomitant medication reported. On 20-JAN-2015, (also reported as 2 weeks ago) the patient was diagnosed with rash on the trunk. On 26-JAN-2015 the patient was diagnosed with shingles. On 09-FEB-2015 the patient experienced back pain. On each of these reported dates the patient was seen in the office by the physician assistant. The patient not sought medical attention. At the time of the report the patient's status was unknown. Additional information has been requested.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Back pain, Flank pain, Herpes zoster, Post herpetic neuralgia, Rash
Clinical narrative: This spontaneous report as received from physician assistant refers to a female patient of unknown age. No medical history and concurrent conditions reported. On an unknown date of April-2011 the patient was vaccinated with ZOSTAVAX (dose, route, lot#, frequency not reported). There was no concomitant medication reported. On 20-JAN-2015, (also reported as 2 weeks ago) the patient was diagnosed with rash on the trunk. On 26-JAN-2015 the patient was diagnosed with shingles. On 09-FEB-2015 the patient experienced back pain. On each of these reported dates the patient was seen in the office by the physician assistant. The patient not sought medical attention. At the time of the report the patient's status was unknown. Additional information has been requested.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Skin lesion
Clinical narrative: This spontaneous report as received from physician assistant refers to a female patient of unknown age. No medical history and concurrent conditions reported. On an unknown date of April-2011 the patient was vaccinated with ZOSTAVAX (dose, route, lot#, frequency not reported). There was no concomitant medication reported. On 20-JAN-2015, (also reported as 2 weeks ago) the patient was diagnosed with rash on the trunk. On 26-JAN-2015 the patient was diagnosed with shingles. On 09-FEB-2015 the patient experienced back pain. On each of these reported dates the patient was seen in the office by the physician assistant. The patient not sought medical attention. At the time of the report the patient's status was unknown. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired product administered, No adverse event
Clinical narrative: Information has been received from a licensed practical nurse concerning a patient of unknown age and gender. On 16-FEB-2015 the patient was inadvertently administered with a dose of ZOSTAVAX (lot# unknown) which expired on 17-JAN-2015, subcutaneously. No adverse effect was reported. Additional information has been requested.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pruritus, Pyrexia, Rash
Clinical narrative: This spontaneous report was received from a consumer refers on behalf of herself as a female patient of 72 year old. No pertinent medical history was reported. Two weeks ago, approximately on 03-FEB-2015, the patient was vaccinated with ZOSTAVAX VIAL (strength, dose, lot# were not reported) at an unspecified store. The next day, approximately on 04-FEB-2015, the patient experienced itchiness around the injection site and low grade fever of 99F. The patient contacted the pharmacy and the pharmacist prescribed BENADRYL (manufacturer and dose unspecified) and ointment cream (manufacturer and dose unspecified). No specific diagnosis was communicated. A couple days later, on an unknown date approximately in February 2015, the patient experienced puffy bumps under her left arm and breast area. The patient did not contact the pharmacy to advise them of these new symptoms. The patient reported instead she applied a cream ointment and week later the bumps dissipated. No product Quality Complaint (PQC) was involved. Action taken was not applicable. On an unknown date approximately in February 2015, the outcome of events was reported as recovered/resolved. Causality was not assessed by the reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Vaccine virus shedding
Clinical narrative: Information has been received from a Nurse concerning a child patient of unknown gender and age. Nurse reported that her unspecified co-worker read an unspecified article stating that newly M-M-R II vaccinated child "shed virus vaccination" which infected the unvaccinated children. She reported that article stated "child was shedding vaccine for 5 weeks". The outcome of events was provided. Additoinal information has been requested.
Sex: F
Vaccine: HEP
Symptoms: Blood culture, Injection site erythema, Injection site induration, Pyrexia, White blood cell count increased
Clinical narrative: Fever 102, redness and induration at the sight 12 cm x 10 cm.
Sex: U
Vaccine: PPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: Information has been received from a registered nurse concerning a patient of unknown age and gender. On 20-FEB-2015 the patient was inadvertently vaccinated with a dose of PNEUMOVAX 23 which expired on 06-DEC-2014 (lot#, dose, strength and route were not reported). No adverse effects reported. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage
Clinical narrative: Information has been received from a pharmacist refers to a two patients of unknown age and gender. In 2015, the patients were vaccinated with a dose of improperly stored ZOSTAVAX (dose, route, lot # and expiration date were not reported). Concomitant medications were not provided. At the time of the report the outcome of the event was unknown. This is one of three reports received from the same reporter. Additional information has been requested.
Sex: F
Vaccine: HEP
Symptoms: Exposure during pregnancy, No adverse event
Clinical narrative: This spontaneous prospective pregnancy report was received from a registered nurse and refers to a female patient of unknown age. No relevant medical history of the patient was reported. On an unknown date in October 2014 the patient was vaccinated with RECOMBIVAX HB dose 2 (lot number, expiry date and route of administration were not reported, therapy type was unspecified). There were no concomitant medications reported. The patient became pregnant with last menstrual period (LMP) on 08-OCT-2014 (number of weeks of pregnancy at the time of the report subtracted from the date of the report) and estimated date of delivery (EDD) of 15-JUL-2015 (reported as became pregnant on an unspecified date 18 weeks prior to 12-FEB-2015). The date of conception was estimated to be 22-OCT-2014. The patient experienced no adverse effect. There was no product quality complaint involved. The pregnancy outcome was pending at the time of the report. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 6 patients of unknown age and gender. On an unknown dates the patients were vaccinated with improperly stored doses of PROQUAD (Merck) (dose, lot # and expiration date were not provided). No adverse effects reported. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a Certified Medical Assistant refers to unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not provided. On an unknown date, the patients were vaccinated with an improperly stored dose of RECOMBIVAX HB (dose, route, lot number and expiry date were not reported). No adverse effects reported. There was no concomitant medication provided. This is one of several reports received from the same reporter. Additional information is not expected, because the reporter refused additional contact.
Age: 0.59
Sex: M
Vaccine: HPV4
Symptoms: Wrong drug administered
Clinical narrative: Medication error, medical assistant did not double check vaccine vial before administering vaccine intended to give PENTACEL but gave GARDASIL.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 65 year old female patient. Pertinent medical history was unknown. On 23-FEB-2015 the patient was vaccinated with ZOSTAVAX (dose, route of administration, anatomical location and lot number was unknown) which was expired on 19-OCT-2014. Concomitant medications were unspecified by reporter. No adverse effects were noted. The outcome of the events was unknown. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a Certified Medical Assistant refers to unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not provided. On an unknown date, the patients were vaccinated with an improperly stored dose of VAQTA (dose, route lot number and expiry date were not reported). No adverse effects reported. There was no concomitant medication provided. This is one of several reports received from the same reporter. Additional information is not expected, because the reporter refused additional contact.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Dizziness, Flank pain, Muscle contractions involuntary, Muscle tightness, Neck pain
Clinical narrative: 15 minutes later severe pain on right side of body from him to chest which lasted about 15 second. Tightness. After 10 minutes felt like having contractions. on right hand and arm felt woozy, felt faint. Lasted a minutes. Patient was concerned so went back to doctor who was closed, to urgent care which was also closed so went to ER. Felt better by the time patient arrived so did not go in. Next day had pain, tightness on back of neck. On 2/22 pain on neck similar to when had shingles before. Today feels fine.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a Certified Medical Assistant refers to unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not provided. On an unknown date, the patients were vaccinated with an improperly stored dose of GARDASIL (dose, route, lot number and expiry date were not reported). No adverse effects reported. There was no concomitant medication provided. Additional information is not expected, because the reporter refused additional contact.
Sex: F
Vaccine: MMR
Symptoms: Adverse event
Clinical narrative: This spontaneous report as received from the patient's mother, refers to her female daughter of unknown age. The patient's medical history and concurrent conditions were not reported. The reporter stated that her daughter was vaccinated on unknown dates in 2003 and 2006, with doses of M-M-R II (Lot number for the vaccine received in 2003 was reported as: 1035N and for the one received in 2006: 1468F) (route of administration and expiration dates were not provided). No concomitant medications were reported. The patient's mother reported that on an unspecified date, after receiving vaccination, her daughter experienced unspecified issues. No more details were given about the adverse event. The outcomes of the unspecified issues were unknown. Additional information has been requested.
Age: 16.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Faecal incontinence, Syncope, Urinary incontinence
Clinical narrative: After the patient received the vaccines, the patient walked to the lobby, to wait 15 minutes before leaving. After a couple minutes (1 or 2) the patient fainted, and had loss of control of the bowel and bladder. The doctor was called, the patient awoke within minutes, and was observed for an additional 30 min. No additional reaction was noted.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a nurse refers to an unspecified patients of unknown age and gender. On 06-FEB-2015, the patients were vaccinated with M-M-R II (strength, dose and route were not reported) (lot # K001231 and expiration date 27-JAN-2016) which were exposed to an unsupported temperature excursion. No adverse effect was reported. No product Quality Complaint (PQC) was involved. This is one of the several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a nurse refers to an unspecified patients of unknown age and gender. On 13-JAN-2015, the patients were vaccinated with M-M-R II INJ (strength, dose and route were not reported) (lot # K001231 and expiration date 27-JAN-2016) which were exposed to an unsupported temperature excursion. No adverse effect was reported. No Product Quality Complaint (PQC) was involved. This is one of the several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. Pertinent medical history was unknown. Since 19-FEB-2015 improperly stored PROQUAD (Merck) (dose, route of administration, anatomical location and lot number was unknown) were administered to unspecified number of patients. Concomitant medications were unspecified by reporter. No adverse effects were noted. The outcome of the events was unknown. This case is linked to the case# 1502USA010390 via same reporter link. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a nurse refers to an unspecified patients of unknown age and gender. On 06-JAN-2015, the patients were vaccinated with M-M-R II INJ (strength, dose and route were not reported) (lot # K001231 and expiration date 27-JAN-2016) which were exposed to an unsupported temperature excursion. No adverse effect was reported. No Product Quality Complaint (PQC) was involved. This is one of the several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. Pertinent medical history was unknown. Since 19-FEB-2015 improperly stored VARIVAX (Merck) (dose, route of administration, anatomical location and lot number was unknown) were administered to unspecified number of patients. Concomitant medications were unspecified by reporter. No adverse effects were noted. The outcome of the events was unknown. This case is linked to the case # 1502USA010291 via same reporter link. Additional information has been requested.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Dermatitis contact, Dry skin, Dyspnoea, Rash, Skin warm
Clinical narrative: Per ER Doctor, Pt presented w/difficulty breathing, already on Prednisone 10mg QD. Skin rash crosses mid-line, not unilateral, consistent w/contact dermatitis, warm dry rash hot likely shingles or scabies given ATARAX and PEPCID.
Sex: U
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: Information has been received from a certified medical assistant referring to a patient of unknown age and gender. On 02-FEB-2015, the patient was inadvertently administered an expired dose of M-M-R II expiry date: 08-NOV-2015, (strength, lot number, route and dose were not reported). No adverse effect reported. Additional information has been requested.
Age: 82.0
Sex: M
Vaccine: PNC13, TDAP
Symptoms: Fatigue, Pain, Rash, Somnolence
Clinical narrative: Pt developed rash, severe soreness, and fatigue for 1 week (sleeping 11 hours/day). Rash is on bilateral arms.
Age: 36.0
Sex: M
Vaccine: HEP, VARCEL
Symptoms: Skin lesion, Varicella post vaccine
Clinical narrative: Developed routine varicella after the vaccination. 17 days after 1st vaccination. Mild case-about 200 lesion-widely scattered. No fever. No resp sx.
Age: 20.0
Sex: M
Vaccine: FLUN3, HEPAB, MMR, TDAP
Symptoms: Adenoidal hypertrophy, Arachnoid cyst, Areflexia, Arthralgia, Asthenia
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 20 year old male. Patient's relevant history and concomitant disease were not reported. Other vaccinations on same day included MMR vaccine, hepatitis a vaccine, hepatitis B vaccine, and Tdap. Patient received FLUMIST (Intranasal) on 08-Oct-2008. On 29-Dec-2009 Medical record received for 2 office visits. Patient presented 06-Nov2008 with bilateral extremity weakness, weakness of the hands and feet and ataxia, difficulty walking and numbness to the abdomen. Recently treated for Community Acquired Pneumonia on 02-Nov-2011. PE (positive) for rhonchi, decreased strength in arms, legs and hips, weakness both ankles, ataxic gait and diminished or absent reflexes. Assessment: Muscle weakness-hands and feet 2 days with truncal numbness. No respiratory issues. Sent to ER to GBS. Community acquired pneumonia. CXR WNL. CBC with Hgb 36.6. HCT 12.6. Platelets 445. Follow up visit for diagnosis with Guillain-Barre Syndrome on 25-Nov-2008. Patient reports still feeling weak, having trouble walking, paresthesias in legs, facial numbness. Unable to open mouth or close Right eye. PE (+) for mild R peripheral VII paresis. Diagnosed with Bell's Palsy. Follow up on 02-Dec-2008. Symptoms improving but not completely resolved. On 11-Feb-2009 Medical record received for DOS 29-Oct-2008 and 02-Nov-2008, 07-Nov-2008, 12-Nov-2008 and 12-Nov-2008, 20-Nov-2008 with initial diagnosis of Pneumonia then Guillain-Barre Syndrome. Patient initially presented with 5 day history of worsening cough with yellow sputum, nasal congestion, vomiting and chills. Diagnosed with pneumonia and treated. Also reported knee and ankle pain. Returned 07-Nov-2008 with c/o numbness/tingling in his fingers and feet progressing to the thighs and difficulty walking. Admitted and treated with IVIG with improvement. Able to walk with cane. Labs and Diagnostics: CXR (positive) for LLL infiltrates. UA (positive) for many WBCs, no sx of UTI. Head CT (positive) for small subarachnoid cyst, pansinusitis, deviated nasal septum and hypertrophy of adenoid. Mycoplasma pneumonia IgG (positive) at 4.05, IgM (negative). CMV IgG (positive), IgM (negative). EBV IgG and IgM (positive). EMG/NCS (positive) R common peroneal nerve. Knee X negative ray (negative). CBC with WBCs 11.5-14.8 with PNA then WNL. ABGs abnormal. UC (positive) for Staph and Diphtheroids. Blood cx (negative). EKG WNL. The patient recovered from the events of Guillain-Barre Syndrome and Bell's Palsy on an unspecified date. The reporter considered the events Guillain-Barre Syndrome and Bell's Palsy to be serious by criteria of hospitalization, and patient also required emergency room.
Age: 20.0
Sex: M
Vaccine: FLUN3, HEPAB, MMR, TDAP
Symptoms: Ataxia, Blood culture negative, Blood gases abnormal, Blood immunoglobulin M normal, Chest X-ray abnormal
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 20 year old male. Patient's relevant history and concomitant disease were not reported. Other vaccinations on same day included MMR vaccine, hepatitis a vaccine, hepatitis B vaccine, and Tdap. Patient received FLUMIST (Intranasal) on 08-Oct-2008. On 29-Dec-2009 Medical record received for 2 office visits. Patient presented 06-Nov2008 with bilateral extremity weakness, weakness of the hands and feet and ataxia, difficulty walking and numbness to the abdomen. Recently treated for Community Acquired Pneumonia on 02-Nov-2011. PE (positive) for rhonchi, decreased strength in arms, legs and hips, weakness both ankles, ataxic gait and diminished or absent reflexes. Assessment: Muscle weakness-hands and feet 2 days with truncal numbness. No respiratory issues. Sent to ER to GBS. Community acquired pneumonia. CXR WNL. CBC with Hgb 36.6. HCT 12.6. Platelets 445. Follow up visit for diagnosis with Guillain-Barre Syndrome on 25-Nov-2008. Patient reports still feeling weak, having trouble walking, paresthesias in legs, facial numbness. Unable to open mouth or close Right eye. PE (+) for mild R peripheral VII paresis. Diagnosed with Bell's Palsy. Follow up on 02-Dec-2008. Symptoms improving but not completely resolved. On 11-Feb-2009 Medical record received for DOS 29-Oct-2008 and 02-Nov-2008, 07-Nov-2008, 12-Nov-2008 and 12-Nov-2008, 20-Nov-2008 with initial diagnosis of Pneumonia then Guillain-Barre Syndrome. Patient initially presented with 5 day history of worsening cough with yellow sputum, nasal congestion, vomiting and chills. Diagnosed with pneumonia and treated. Also reported knee and ankle pain. Returned 07-Nov-2008 with c/o numbness/tingling in his fingers and feet progressing to the thighs and difficulty walking. Admitted and treated with IVIG with improvement. Able to walk with cane. Labs and Diagnostics: CXR (positive) for LLL infiltrates. UA (positive) for many WBCs, no sx of UTI. Head CT (positive) for small subarachnoid cyst, pansinusitis, deviated nasal septum and hypertrophy of adenoid. Mycoplasma pneumonia IgG (positive) at 4.05, IgM (negative). CMV IgG (positive), IgM (negative). EBV IgG and IgM (positive). EMG/NCS (positive) R common peroneal nerve. Knee X negative ray (negative). CBC with WBCs 11.5-14.8 with PNA then WNL. ABGs abnormal. UC (positive) for Staph and Diphtheroids. Blood cx (negative). EKG WNL. The patient recovered from the events of Guillain-Barre Syndrome and Bell's Palsy on an unspecified date. The reporter considered the events Guillain-Barre Syndrome and Bell's Palsy to be serious by criteria of hospitalization, and patient also required emergency room.
Age: 20.0
Sex: M
Vaccine: FLUN3, HEPAB, MMR, TDAP
Symptoms: Chills, Computerised tomogram head abnormal, Cough, Culture urine positive, Cytomegalovirus test negative
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 20 year old male. Patient's relevant history and concomitant disease were not reported. Other vaccinations on same day included MMR vaccine, hepatitis a vaccine, hepatitis B vaccine, and Tdap. Patient received FLUMIST (Intranasal) on 08-Oct-2008. On 29-Dec-2009 Medical record received for 2 office visits. Patient presented 06-Nov2008 with bilateral extremity weakness, weakness of the hands and feet and ataxia, difficulty walking and numbness to the abdomen. Recently treated for Community Acquired Pneumonia on 02-Nov-2011. PE (positive) for rhonchi, decreased strength in arms, legs and hips, weakness both ankles, ataxic gait and diminished or absent reflexes. Assessment: Muscle weakness-hands and feet 2 days with truncal numbness. No respiratory issues. Sent to ER to GBS. Community acquired pneumonia. CXR WNL. CBC with Hgb 36.6. HCT 12.6. Platelets 445. Follow up visit for diagnosis with Guillain-Barre Syndrome on 25-Nov-2008. Patient reports still feeling weak, having trouble walking, paresthesias in legs, facial numbness. Unable to open mouth or close Right eye. PE (+) for mild R peripheral VII paresis. Diagnosed with Bell's Palsy. Follow up on 02-Dec-2008. Symptoms improving but not completely resolved. On 11-Feb-2009 Medical record received for DOS 29-Oct-2008 and 02-Nov-2008, 07-Nov-2008, 12-Nov-2008 and 12-Nov-2008, 20-Nov-2008 with initial diagnosis of Pneumonia then Guillain-Barre Syndrome. Patient initially presented with 5 day history of worsening cough with yellow sputum, nasal congestion, vomiting and chills. Diagnosed with pneumonia and treated. Also reported knee and ankle pain. Returned 07-Nov-2008 with c/o numbness/tingling in his fingers and feet progressing to the thighs and difficulty walking. Admitted and treated with IVIG with improvement. Able to walk with cane. Labs and Diagnostics: CXR (positive) for LLL infiltrates. UA (positive) for many WBCs, no sx of UTI. Head CT (positive) for small subarachnoid cyst, pansinusitis, deviated nasal septum and hypertrophy of adenoid. Mycoplasma pneumonia IgG (positive) at 4.05, IgM (negative). CMV IgG (positive), IgM (negative). EBV IgG and IgM (positive). EMG/NCS (positive) R common peroneal nerve. Knee X negative ray (negative). CBC with WBCs 11.5-14.8 with PNA then WNL. ABGs abnormal. UC (positive) for Staph and Diphtheroids. Blood cx (negative). EKG WNL. The patient recovered from the events of Guillain-Barre Syndrome and Bell's Palsy on an unspecified date. The reporter considered the events Guillain-Barre Syndrome and Bell's Palsy to be serious by criteria of hospitalization, and patient also required emergency room.
Age: 20.0
Sex: M
Vaccine: FLUN3, HEPAB, MMR, TDAP
Symptoms: Cytomegalovirus test positive, Dyskinesia, Electrocardiogram normal, Electromyogram abnormal, Epstein-Barr virus antibody positive
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 20 year old male. Patient's relevant history and concomitant disease were not reported. Other vaccinations on same day included MMR vaccine, hepatitis a vaccine, hepatitis B vaccine, and Tdap. Patient received FLUMIST (Intranasal) on 08-Oct-2008. On 29-Dec-2009 Medical record received for 2 office visits. Patient presented 06-Nov2008 with bilateral extremity weakness, weakness of the hands and feet and ataxia, difficulty walking and numbness to the abdomen. Recently treated for Community Acquired Pneumonia on 02-Nov-2011. PE (positive) for rhonchi, decreased strength in arms, legs and hips, weakness both ankles, ataxic gait and diminished or absent reflexes. Assessment: Muscle weakness-hands and feet 2 days with truncal numbness. No respiratory issues. Sent to ER to GBS. Community acquired pneumonia. CXR WNL. CBC with Hgb 36.6. HCT 12.6. Platelets 445. Follow up visit for diagnosis with Guillain-Barre Syndrome on 25-Nov-2008. Patient reports still feeling weak, having trouble walking, paresthesias in legs, facial numbness. Unable to open mouth or close Right eye. PE (+) for mild R peripheral VII paresis. Diagnosed with Bell's Palsy. Follow up on 02-Dec-2008. Symptoms improving but not completely resolved. On 11-Feb-2009 Medical record received for DOS 29-Oct-2008 and 02-Nov-2008, 07-Nov-2008, 12-Nov-2008 and 12-Nov-2008, 20-Nov-2008 with initial diagnosis of Pneumonia then Guillain-Barre Syndrome. Patient initially presented with 5 day history of worsening cough with yellow sputum, nasal congestion, vomiting and chills. Diagnosed with pneumonia and treated. Also reported knee and ankle pain. Returned 07-Nov-2008 with c/o numbness/tingling in his fingers and feet progressing to the thighs and difficulty walking. Admitted and treated with IVIG with improvement. Able to walk with cane. Labs and Diagnostics: CXR (positive) for LLL infiltrates. UA (positive) for many WBCs, no sx of UTI. Head CT (positive) for small subarachnoid cyst, pansinusitis, deviated nasal septum and hypertrophy of adenoid. Mycoplasma pneumonia IgG (positive) at 4.05, IgM (negative). CMV IgG (positive), IgM (negative). EBV IgG and IgM (positive). EMG/NCS (positive) R common peroneal nerve. Knee X negative ray (negative). CBC with WBCs 11.5-14.8 with PNA then WNL. ABGs abnormal. UC (positive) for Staph and Diphtheroids. Blood cx (negative). EKG WNL. The patient recovered from the events of Guillain-Barre Syndrome and Bell's Palsy on an unspecified date. The reporter considered the events Guillain-Barre Syndrome and Bell's Palsy to be serious by criteria of hospitalization, and patient also required emergency room.
Age: 20.0
Sex: M
Vaccine: FLUN3, HEPAB, MMR, TDAP
Symptoms: Eyelid function disorder, Gait disturbance, Guillain-Barre syndrome, Haematocrit decreased, Haemoglobin increased
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 20 year old male. Patient's relevant history and concomitant disease were not reported. Other vaccinations on same day included MMR vaccine, hepatitis a vaccine, hepatitis B vaccine, and Tdap. Patient received FLUMIST (Intranasal) on 08-Oct-2008. On 29-Dec-2009 Medical record received for 2 office visits. Patient presented 06-Nov2008 with bilateral extremity weakness, weakness of the hands and feet and ataxia, difficulty walking and numbness to the abdomen. Recently treated for Community Acquired Pneumonia on 02-Nov-2011. PE (positive) for rhonchi, decreased strength in arms, legs and hips, weakness both ankles, ataxic gait and diminished or absent reflexes. Assessment: Muscle weakness-hands and feet 2 days with truncal numbness. No respiratory issues. Sent to ER to GBS. Community acquired pneumonia. CXR WNL. CBC with Hgb 36.6. HCT 12.6. Platelets 445. Follow up visit for diagnosis with Guillain-Barre Syndrome on 25-Nov-2008. Patient reports still feeling weak, having trouble walking, paresthesias in legs, facial numbness. Unable to open mouth or close Right eye. PE (+) for mild R peripheral VII paresis. Diagnosed with Bell's Palsy. Follow up on 02-Dec-2008. Symptoms improving but not completely resolved. On 11-Feb-2009 Medical record received for DOS 29-Oct-2008 and 02-Nov-2008, 07-Nov-2008, 12-Nov-2008 and 12-Nov-2008, 20-Nov-2008 with initial diagnosis of Pneumonia then Guillain-Barre Syndrome. Patient initially presented with 5 day history of worsening cough with yellow sputum, nasal congestion, vomiting and chills. Diagnosed with pneumonia and treated. Also reported knee and ankle pain. Returned 07-Nov-2008 with c/o numbness/tingling in his fingers and feet progressing to the thighs and difficulty walking. Admitted and treated with IVIG with improvement. Able to walk with cane. Labs and Diagnostics: CXR (positive) for LLL infiltrates. UA (positive) for many WBCs, no sx of UTI. Head CT (positive) for small subarachnoid cyst, pansinusitis, deviated nasal septum and hypertrophy of adenoid. Mycoplasma pneumonia IgG (positive) at 4.05, IgM (negative). CMV IgG (positive), IgM (negative). EBV IgG and IgM (positive). EMG/NCS (positive) R common peroneal nerve. Knee X negative ray (negative). CBC with WBCs 11.5-14.8 with PNA then WNL. ABGs abnormal. UC (positive) for Staph and Diphtheroids. Blood cx (negative). EKG WNL. The patient recovered from the events of Guillain-Barre Syndrome and Bell's Palsy on an unspecified date. The reporter considered the events Guillain-Barre Syndrome and Bell's Palsy to be serious by criteria of hospitalization, and patient also required emergency room.
Age: 20.0
Sex: M
Vaccine: FLUN3, HEPAB, MMR, TDAP
Symptoms: Hypoaesthesia, Immunoglobulin therapy, Muscular weakness, Mycoplasma test positive, Nasal congestion
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 20 year old male. Patient's relevant history and concomitant disease were not reported. Other vaccinations on same day included MMR vaccine, hepatitis a vaccine, hepatitis B vaccine, and Tdap. Patient received FLUMIST (Intranasal) on 08-Oct-2008. On 29-Dec-2009 Medical record received for 2 office visits. Patient presented 06-Nov2008 with bilateral extremity weakness, weakness of the hands and feet and ataxia, difficulty walking and numbness to the abdomen. Recently treated for Community Acquired Pneumonia on 02-Nov-2011. PE (positive) for rhonchi, decreased strength in arms, legs and hips, weakness both ankles, ataxic gait and diminished or absent reflexes. Assessment: Muscle weakness-hands and feet 2 days with truncal numbness. No respiratory issues. Sent to ER to GBS. Community acquired pneumonia. CXR WNL. CBC with Hgb 36.6. HCT 12.6. Platelets 445. Follow up visit for diagnosis with Guillain-Barre Syndrome on 25-Nov-2008. Patient reports still feeling weak, having trouble walking, paresthesias in legs, facial numbness. Unable to open mouth or close Right eye. PE (+) for mild R peripheral VII paresis. Diagnosed with Bell's Palsy. Follow up on 02-Dec-2008. Symptoms improving but not completely resolved. On 11-Feb-2009 Medical record received for DOS 29-Oct-2008 and 02-Nov-2008, 07-Nov-2008, 12-Nov-2008 and 12-Nov-2008, 20-Nov-2008 with initial diagnosis of Pneumonia then Guillain-Barre Syndrome. Patient initially presented with 5 day history of worsening cough with yellow sputum, nasal congestion, vomiting and chills. Diagnosed with pneumonia and treated. Also reported knee and ankle pain. Returned 07-Nov-2008 with c/o numbness/tingling in his fingers and feet progressing to the thighs and difficulty walking. Admitted and treated with IVIG with improvement. Able to walk with cane. Labs and Diagnostics: CXR (positive) for LLL infiltrates. UA (positive) for many WBCs, no sx of UTI. Head CT (positive) for small subarachnoid cyst, pansinusitis, deviated nasal septum and hypertrophy of adenoid. Mycoplasma pneumonia IgG (positive) at 4.05, IgM (negative). CMV IgG (positive), IgM (negative). EBV IgG and IgM (positive). EMG/NCS (positive) R common peroneal nerve. Knee X negative ray (negative). CBC with WBCs 11.5-14.8 with PNA then WNL. ABGs abnormal. UC (positive) for Staph and Diphtheroids. Blood cx (negative). EKG WNL. The patient recovered from the events of Guillain-Barre Syndrome and Bell's Palsy on an unspecified date. The reporter considered the events Guillain-Barre Syndrome and Bell's Palsy to be serious by criteria of hospitalization, and patient also required emergency room.
Age: 20.0
Sex: M
Vaccine: FLUN3, HEPAB, MMR, TDAP
Symptoms: Nasal septum deviation, Nerve conduction studies abnormal, Paraesthesia, Peripheral nerve paresis, Platelet count increased
Clinical narrative: This report to VAERS provides the following narrative: A report from VAERS (Health Authority) concerns a 20 year old male. Patient's relevant history and concomitant disease were not reported. Other vaccinations on same day included MMR vaccine, hepatitis a vaccine, hepatitis B vaccine, and Tdap. Patient received FLUMIST (Intranasal) on 08-Oct-2008. On 29-Dec-2009 Medical record received for 2 office visits. Patient presented 06-Nov2008 with bilateral extremity weakness, weakness of the hands and feet and ataxia, difficulty walking and numbness to the abdomen. Recently treated for Community Acquired Pneumonia on 02-Nov-2011. PE (positive) for rhonchi, decreased strength in arms, legs and hips, weakness both ankles, ataxic gait and diminished or absent reflexes. Assessment: Muscle weakness-hands and feet 2 days with truncal numbness. No respiratory issues. Sent to ER to GBS. Community acquired pneumonia. CXR WNL. CBC with Hgb 36.6. HCT 12.6. Platelets 445. Follow up visit for diagnosis with Guillain-Barre Syndrome on 25-Nov-2008. Patient reports still feeling weak, having trouble walking, paresthesias in legs, facial numbness. Unable to open mouth or close Right eye. PE (+) for mild R peripheral VII paresis. Diagnosed with Bell's Palsy. Follow up on 02-Dec-2008. Symptoms improving but not completely resolved. On 11-Feb-2009 Medical record received for DOS 29-Oct-2008 and 02-Nov-2008, 07-Nov-2008, 12-Nov-2008 and 12-Nov-2008, 20-Nov-2008 with initial diagnosis of Pneumonia then Guillain-Barre Syndrome. Patient initially presented with 5 day history of worsening cough with yellow sputum, nasal congestion, vomiting and chills. Diagnosed with pneumonia and treated. Also reported knee and ankle pain. Returned 07-Nov-2008 with c/o numbness/tingling in his fingers and feet progressing to the thighs and difficulty walking. Admitted and treated with IVIG with improvement. Able to walk with cane. Labs and Diagnostics: CXR (positive) for LLL infiltrates. UA (positive) for many WBCs, no sx of UTI. Head CT (positive) for small subarachnoid cyst, pansinusitis, deviated nasal septum and hypertrophy of adenoid. Mycoplasma pneumonia IgG (positive) at 4.05, IgM (negative). CMV IgG (positive), IgM (negative). EBV IgG and IgM (positive). EMG/NCS (positive) R common peroneal nerve. Knee X negative ray (negative). CBC with WBCs 11.5-14.8 with PNA then WNL. ABGs abnormal. UC (positive) for Staph and Diphtheroids. Blood cx (negative). EKG WNL. The patient recovered from the events of Guillain-Barre Syndrome and Bell's Palsy on an unspecified date. The reporter considered the events Guillain-Barre Syndrome and Bell's Palsy to be serious by criteria of hospitalization, and patient also required emergency room.